SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-005920
Filing Date
2024-06-21
Accepted
2024-06-21 08:41:02
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3999
  Complete submission text file 0001209191-24-005920.txt   5453
Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Bristol James Arthur (Reporting) CIK: 0001715153 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40602 | Film No.: 241058403

Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Issuer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)